Aims and objectives

The ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) gathers physicians, veterinarians, microbiologists, and scientists. Together, we are dedicated to improving the understanding of clinical presentation and epidemiology (including antimicrobial resistance) of Mycoplasma, Ureaplasma, and Chlamydiales infections in both humans and animals. Our collaborative mission aims to:

  • Define the clinical presentation of infections from various Mycoplasma and Ureaplasma genus, as well as those classified within the Chlamydiae phylum, both in humans and in animals
  • Study the epidemiology of Mycoplasma and Chlamydiae infections and the transmission modes of new chlamydia-related bacteria
  • Improve diagnostic tools for challenging-to-culture Mycoplasma and Chlamydiae, which are better detected by molecular assays
  • Develop genomics capacity to better understand the biology of Chlamydiae and Mycoplasma, while providing sequences needed for molecular epidemiology
  • Identify new drug targets and refine treatment protocols and duration for the large diversity of infections due to Chlamydiae and Mycoplasma, from very common and easy-to-treat infections like chlamydial urethritis to rare but serious cases such as Mycoplasma hominis endocarditis
  • Understand the evolution of Chlamydiae phylum’s mollicutes
  • Engage with active collaboration with relevant international scientific societies such as the International Organization for Mycoplasmology (IOM), the European Society for Chlamydia research (ESCR) and the European Society for Chlamydioses, Coxiellosis, Anaplasmosis, Rickettsioses and Bartonellosis (ESCCAR)

Activities and resources

ESGMAC Newsletter, Summer 2024, June 2024

Download


ESGMAC Newsletter, Spring 2024, 20 March 2024

Download


ESGMAC Newsletter, Spring 2023, 14 April 2023

Download


ESGMAC Newsletter, Summer 2023, 30 August 2023

Download


ESGMAC Newsletter, Winter 2023, 6 December 2023

Download

Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions.

Meyer Sauteur PM, Beeton ML for the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC Mycoplasma pneumoniae Surveillance (MAPS) study group. Lancet Microbe. 2024;5(2):e100–e101.

Go to publication


Mycoplasma pneumoniae: gone forever?

Meyer Sauteur PM, Beeton ML for the ESGMAC the ESGMAC MAPS study group. Lancet Microbe. 2023;4(10):e763.

Go to publication

ECMCR 2024

6 March 2024

Go to webinar


Research and clinical aspects of Chlamydiales and Mycoplasma

24 January 2024

Go to webinar


Update on Chlamydia trachomatis

30 March 2023

Go to webinar


ESGMAC webinar on zoonotic Chlamydia and Chlamydia like bacteria

18 October 2023


Research and clinical aspects of Chlamydiales and Mycoplasma

13 December 2023

Go to webinar

Executive Committee

  Gilbert Greub

Gilbert Greub

Chairperson
University Hospital Centre (CHUV). Institute of Microbiology.
Mollie-Margot, Switzerland
  Mirja Puolakkainen

Mirja Puolakkainen

Secretary
University of Helsinki and Helsinki University Hospital. Virology.
Helsinki, Finland
  Barbara Van Der Pol

Barbara Van Der Pol

Treasurer
University of Alabama at Birmingham. Infectious Diseases.
Birmingham, United States
  Sylvia Bruisten

Sylvia Bruisten

Education Officer
Public Health Service GGD Amsterdam. Infectious Diseases.
Amsterdam, Netherlands
  Jorgen Skov Jensen

Jorgen Skov Jensen

Science Officer
Statens Serum Institut.
Copenhagen, Denmark

Contact

If you have questions or comments for our study group, we warmly invite you to contact us!

Contact form